Biobank of blood samples and health information from people with pulmonary hypertension
Collects blood samples and health records from adults with, or possibly with, pulmonary hypertension.
Plain-language title generated from the registry record
Registry title: Pulmonary Hypertension (PH) Biorepository for Translational Research
Key facts
- Where
- Baltimore, Bethesda, and Falls Church, United StatesSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT07647549, who can take part
Where in United States
- University of Maryland Medical Center at Baltimore (UMB)Baltimore, United StatesNot yet recruiting
- National Institutes of Health Clinical CenterBethesda, United StatesTaking people
- Inova Fairfax HospitalFalls Church, United StatesNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Institutes of Health Clinical Center (CC)
- Trial code
- NCT07647549
- Record updated
- 22 October 2026
- Original description
Background:Read full original descriptionShow less
Pulmonary Hypertension (PH) Biorepository for Translational Research
Background:
Pulmonary hypertension (PH) is high blood pressure in the blood vessels of the lungs. It can lead to heart failure and death if not treated. Researchers want to create a repository of blood samples and health information collected from people with PH. They hope to use this information to find better ways to diagnose and treat PH.
Objective:
To collect blood samples and health information from people suspected of or diagnosed with PH.
Eligibility:
People aged 18 years and older who have or may have PH.
Design:
Researchers will collect information from participants medical records.
Participants will have blood drawn from a vein. About 3 tablespoons will be collected during the study visit. The visit will last about 1 hour.
Participants may choose to provide new blood samples at follow-up visits. Updated medical information may also be collected.
Participants may continue to participate as long as the study is ongoing. Participants may opt out of providing new blood samples but remain in the study.
All study samples will be stored at the National Institutes of Health. Health information will be stored in secure databases.
Exclusion: Any individual who does not meet all inclusion criteria or is deemed by the local investigator not to be a blood draw candidate will be excluded from participating in this study.
INCLUSION CRITERIA:; Provision of signed and dated informed consent form; Males and females aged >=18 years old; Suspected of or diagnosed with PH; Able to understand and willing to sign a written informed consent document.